David Pernock - Net Worth and Insider Trading
David Pernock Net Worth
The estimated net worth of David Pernock is at least $21,806 dollars as of 2024-11-29. David Pernock is the Chairman and CEO of Fibrocell Science Inc and owns about 7,040 shares of Fibrocell Science Inc (FCSC) stock worth over $21,120. David Pernock is also the Pres. & Chief Comm. Officer of Eagle Pharmaceuticals Inc and owns about 966 shares of Eagle Pharmaceuticals Inc (EGRX) stock worth over $686. Details can be seen in David Pernock's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Pernock has not made any transactions after 2017-05-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Pernock
David Pernock Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Pernock owns 2 companies in total, including Eagle Pharmaceuticals Inc (EGRX) , and Fibrocell Science Inc (FCSC) .
Click here to see the complete history of David Pernock’s form 4 insider trades.
Insider Ownership Summary of David Pernock
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EGRX | Eagle Pharmaceuticals Inc | 2017-05-19 | director |
| FCSC | Fibrocell Science Inc | 2016-12-02 | director & Chairman and CEO |
David Pernock Latest Holdings Summary
David Pernock currently owns a total of 2 stocks. Among these stocks, David Pernock owns 7,040 shares of Fibrocell Science Inc (FCSC) as of December 2, 2016, with a value of $21,120 and a weighting of 96.85%. David Pernock also owns 966 shares of Eagle Pharmaceuticals Inc (EGRX) as of May 19, 2017, with a value of $686 and a weighting of 3.15%.
Latest Holdings of David Pernock
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FCSC | Fibrocell Science Inc | 2016-12-02 | 7,040 | 3.00 | 21,120 |
| EGRX | Eagle Pharmaceuticals Inc | 2017-05-19 | 966 | 0.71 | 686 |
Holding Weightings of David Pernock
David Pernock Form 4 Trading Tracker
According to the SEC Form 4 filings, David Pernock has made a total of 0 transactions in Fibrocell Science Inc (FCSC) over the past 5 years. The most-recent trade in Fibrocell Science Inc is the acquisition of 3,333 shares on December 2, 2016, which cost David Pernock around $46,000.
According to the SEC Form 4 filings, David Pernock has made a total of 0 transactions in Eagle Pharmaceuticals Inc (EGRX) over the past 5 years. The most-recent trade in Eagle Pharmaceuticals Inc is the acquisition of 255 shares on May 19, 2017, which cost David Pernock around $20,321.
Insider Trading History of David Pernock
- 1
David Pernock Trading Performance
GuruFocus tracks the stock performance after each of David Pernock's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Pernock is 13.6%. GuruFocus also compares David Pernock's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Pernock within 3 months outperforms 5 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Pernock's insider trading performs compared to the benchmark.
Performance of David Pernock
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6 | | | | | |
| Relative Return to S&P 500(%) | 5.55 | | | | | |
David Pernock Ownership Network
David Pernock Owned Company Details
What does Eagle Pharmaceuticals Inc do?
Who are the key executives at Eagle Pharmaceuticals Inc?
David Pernock is the director of Eagle Pharmaceuticals Inc. Other key executives at Eagle Pharmaceuticals Inc include director & President and CEO Scott Tarriff , EVP & Chief Commercial Officer Michael Shawn Moran , and Chief Medical Officer Judith Ng-cashin .
Eagle Pharmaceuticals Inc (EGRX) Insider Trades Summary
Over the past 18 months, David Pernock made no insider transaction in Eagle Pharmaceuticals Inc (EGRX). Other recent insider transactions involving Eagle Pharmaceuticals Inc (EGRX) include a net sale of 41,864 shares made by Scott Tarriff ,
In summary, during the past 3 months, insiders sold 0 shares of Eagle Pharmaceuticals Inc (EGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 41,864 shares of Eagle Pharmaceuticals Inc (EGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 41,864 shares.
Eagle Pharmaceuticals Inc (EGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eagle Pharmaceuticals Inc Insider Transactions
David Pernock Mailing Address
Above is the net worth, insider trading, and ownership report for David Pernock. You might contact David Pernock via mailing address: 405 Eagleview Boulevard, Exton Pa 19341.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
